| PEB0148 | Racial/ethnical disparities in HCV testing among MSM in HIV care | E-poster | B12 |
| PEB0149 | Prevalence and predictors of tobacco use in patients living with HIV/HCV co-infection: Findings from a large urban tertiary center | E-poster | B12 |
| PEB0150 | Evolution of HIV reservoir and viral splicing after the elimination of HCV with DAAs in HIV/HCV patients | E-poster | B12 |
| PEB0151 | Costs and clinical outcomes of a simplified HCV treatment algorithm for Ukraine | E-poster | B12 |
| PEB0152 | High SVR with ledipasvir/sofosbuvir +/- ribavirin among PWID and PWH in Ukraine | E-poster | B12 |
| PEB0153 | Creating a multi-site HCV care cascade for HIV/HCV co-infected persons receiving care in 11 CT clinics using data to care methods | E-poster | B12 |
| PEB0154 | Predictors associated with better response to Japanese aluminum-free hepatitis A vaccine to Japanese people living with HIV: Lessons from the hepatitis A outbreaks in Tokyo | E-poster | B13 |
| PEB0155 | High co-infection with HBV, HCV and syphilis, and low CD4/CD8 ratio among HIV/AIDS patients in Guangzhou, China 2014-2017 | E-poster | B13 |
| PEB0156 | Serologic response to hepatitis A vaccination among HIV-infected individuals | E-poster | B13 |
| PEB0157 | Hepatitis B co-infection in HIV-infected patients receiving multi-drug resistant tuberculosis (MDRTB) treatment at the Botsabelo Hospital in Lesotho | E-poster | B13 |